Tag: SHR4849

Please Enable JavaScript in your Browser to Visit this Site.

#mdp-ungrabber-js-disabled { position: fixed; top: 0; left: 0; height: 100%; width: 100%; z-index: 999999; text-align: center; background-color: #FFFFFF; color: #000000; font-size: 40px; display: flex; align-items: center; justify-content: center; }

Tag: SHR4849

IDEAYA Biosciences Enters into Unique License with Hengrui Pharma for SHR-4849, a Novel Part 1 DLL3 Topo-I-Payload ADC Concentrating on SCLC and NET Stable Tumors

About US

Quick Link

Top Categories

Subscribe to our newsletter